Author: UW CTI

Investigators have dosed the first participant in a phase 3 trial for mRNA-1083 (Moderna), a combination vaccine candidate that provides protection against influenza and COVID-19. Investigators anticipate enrolling approximately 8000 individuals in the Northern Hemisphere for the trial, according to a Moderna press release....

At the outset, cancer vaccines were plagued with false starts and modest success at best. But they now represent a promising therapeutic strategy in the immunotherapy of solid tumors....

New clinical treatments for diseases are conceived in a laboratory, then tested on animals or through simulations, and finally studied on human beings if deemed promising enough. Moving from point to point in this cycle is rarely a straight line, and costly and time-consuming trial-and-...

Did you fall into the clinical research profession? This is a question we have often asked attendees at national clinical research conferences like those held annually by ACRP. Responses have mostly been a resounding “Yes”! Unfortunately, many people find out about clinical research and clinical...

New clinical-trial data suggest that an antiviral pill called ensitrelvir shortens the duration of two unpleasant symptoms of COVID-19: loss of smell and taste. The medication is among the first to alleviate these effects and, unlike other COVID-19 treatments, is not reserved only for people...